Uptravi
Uptravi Uptravi (ponesimod) is a selective sphingosine‑1‑phosphate receptor‑1 (S1P₁) modulator approved for the treatment of relapsing‑remitting multiple sclerosis (RRMS). Mechanism of Action Selective S1P₁ agonist that sequesters circulating lymphocytes in…